Dr. Wenninger has worked for more than 30 years in the international healthcare business. He has been a member of the Board of Management at Bayer AG, Germany, and Chairman of the Board of Bayer Corporation, USA. Dr. Wenninger is Chairman of the Board of Noxxon Pharma AG, Berlin and a member of the Board of Directors of Evotec AG, Hamburg, Paion AG, Aachen, Recordati Industria Chimica e Farmaceutica S.p.A., Milan and a member of the Novo Advisory Group, Denmark and a member of the Board of the Robert-Koch-Foundation, Germany. Dr. Wenninger holds a PhD and an MBA from the University at Munich, Germany. Dr. Wenninger was first elected to the Board of Directors of Santaris Pharma A/S in 2006.